Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Transplantation and the Use of Raltegravir in HIV-Infected Patients

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2016 by Duke University
Sponsor:
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Duke University
ClinicalTrials.gov Identifier:
NCT01793467
First received: February 13, 2013
Last updated: July 22, 2016
Last verified: July 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: October 2017 (Final data collection date for primary outcome measure)